Skip to main content

Stanislav Glezer

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Stanislav Glezer

Stanislav Glezer is recorded as CTO at Inogen Inc (INGN). Inogen Inc reported in an 8-K filed April 15, 2024 that Stanislav Glezer was terminated as Executive Vice President, R&D and Chief Medical Officer. The proxy statement of Inogen Inc reports total compensation of $1,152,018 for Stanislav Glezer in fiscal 2024, including a base salary of $220,874. Disclosed compensation is on record for 4 fiscal years.

“On April 11, 2024, Inogen, Inc. (the “Company”) and Dr. Stanislav Glezer, Executive Vice President, R&D and Chief Medical Officer of the Company, mutually determined that Dr. Glezer would separate from the Company on or before May 3, 2024.”
Inogen Inc Form 8-K, filed April 15, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Inogen Inc

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Inogen Inc (INGN) $220,874 $1,152,018
2023 Inogen Inc (INGN) $492,577 $1,455,355
2022 Inogen Inc (INGN) $468,423 $2,542,751
2021 Inogen Inc (INGN) $233,846 $1,428,285

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.